Ticker Details
Illumina, Inc. Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products.
IPO Date:	July 28, 2000
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$17.99B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.15 | 1.72%
Avg Daily Range (30 D):	$2.88 | 2.14%
Avg Daily Range (90 D):	$2.47 | 1.98%

Institutional Daily Volume
Avg Daily Volume:	1.34M
Avg Daily Volume (30 D):	2M
Avg Daily Volume (90 D):	1.64M

Trade Size
Avg Trade Size (Sh.):	91
Avg Trade Size (Sh.) (30 D):	55
Avg Trade Size (Sh.) (90 D):	48

Institutional Trades
Total Institutional Trades:	24,897
Avg Institutional Trade:	$6.98M
Avg Institutional Trade (30 D):	$9.64M
Avg Institutional Trade (90 D):	$10.27M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$20.59M
Avg Closing Trade (30 D):	$34.13M
Avg Closing Trade (90 D):	$31.12M
Avg Closing Volume:	116.85K

News

Feb 13, 2026 @ 3:00 PM Decoding Our DNA: The Human Impact Behind SNP Geno... Source: Towards Healthcare

Feb 10, 2026 @ 12:00 PM Standard BioTools to Announce Fourth Quarter and F... Source: Na

Feb 7, 2026 @ 3:05 AM Could Nvidia Be the Best Way to Play the AI Boom i... Source: James Hires

Jan 26, 2026 @ 4:00 PM Microarrays Market Size to Accumulate Around USD 1... Source: Sns Insider

Jan 22, 2026 @ 3:35 AM Next Generation Sequencing Market Size to Worth US... Source: Nova One Advisor

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$5.47	$2.17	$5.47
Diluted EPS	$5.45	$2.16	$5.45
Revenue	$4.34B	$1.16B	$4.34B
Gross Profit	$2.87B	$759M	$2.87B
Net Income / Loss	$850M	$334M	$850M
Operating Income / Loss	$807M	$201M	$807M
Cost of Revenue	$1.47B	$400M	$1.47B
Net Cash Flow	$291M	$368M	$291M
PE Ratio	22.55

Splits
Sep 23, 2008	2:1